Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading people...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

Home
/People
/Mark Jurgens

MJ

§ Investor Profile

Mark Jurgens

Updated:Apr 2, 2026

About News Experience Investments FAQs

Quick Facts

Role: Executive Director, Head of External Scientific Collaboration
Company: Tmunity Therapeutics
Status: Active
Type: Investor

Subscribe, Save or Share

Join 25K+ founders & VCs who start their week informed.

Recent News & Mentions

Oct 1, 2019FundingTmunity Therapeutics - Series B Apr 1, 2018FundingTmunity Therapeutics - Series A Jan 23, 2018FundingTmunity Therapeutics - Series A Jan 12, 2016FundingTmunity Therapeutics - Other Equity Apr 28, 2014FundingKite Pharma - Debt May 16, 2013FundingKite Pharma - Other Equity / Series A Mar 9, 2011FundingKite Pharma - Other Equity

Experience

Executive Director, Head of External Scientific CollaborationCurrent

Tmunity Therapeutics

Present - Present

Frequently Asked Questions

Who is Mark Jurgens?

Mark Jurgens is Executive Director, Head of External Scientific Collaboration at Tmunity Therapeutics.